Page 978 - Read Online

Lonardo et al. Hepatoma Res 2020;6:83 I http://dx.doi.org/10.20517/2394-5079.2020.89 Page 11 of 12

32. Wu EM, Wong LL, Hernandez BY, et al. Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/
steatohepatitis and liver transplantation. Hepatoma Res 2018;4:66.
33. Rich NE, Murphy CC, Yopp AC, Tiro J, Marrero JA, Singal AG. Sex disparities in presentation and prognosis of 1110 patients with
hepatocellular carcinoma. Aliment Pharmacol Ther 2020;52:701-9.
34. Phipps M, Livanos A, Guo A, et al. Gender matters: characteristics of hepatocellular carcinoma in women from a large, multicenter study
in the United States. Am J Gastroenterol 2020;115:1486-95.
35. Ladenheim MR, Kim NG, Nguyen P, et al. Sex differences in disease presentation, treatment and clinical outcomes of patients with
hepatocellular carcinoma: a single-centre cohort study. BMG Open Gastroenterol 2016;3:e000107.
36. Lam CM, Yong JL, Chan AO, et al. Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related? J
Clin Gastroenterol 2005;39:533-9.
37. Dohmen K, Shigematsu H, Irie K, et al. Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol
2003;18:267-72.
38. Tangkijvanich P, Mahachai V, Suwangool P, et al. Gender difference in clinicopathologic features and survival of patients with
hepatocellular carcinoma. World J Gastroenterol 2004;10:1547-50.
39. Lai MW, Chu YD, Lin CL, et al. Is there a sex difference in postoperative prognosis of hepatocellular carcinoma? BMC Cancer
2019;19:250.
40. Li S, Hong M, Tan HY, Wang N, Feng Y. Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver
Diseases. Oxid Med Cell Longev 2016;2016:423406.
41. Yang SF, Chang CW, Wei RJ, Shiue YL, Wang SN, Yeh YT. Involvement of DNA damage response pathways in hepatocellular
carcinoma. Biomed Res Int 2014;2014:153867.
42. Nishida N, Kudo M. Oxidative stress and epigenetic instability in human hepatocarcinogenesis. Dig Dis 2013;31:447-53.
43. O’Hagan HM, Wang W, Sen S, et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb
members to promoter CpG Islands. Cancer Cell 2011;20:606-19.
44. Nishida N, Kudo M, Nagasaka T, Ikai I, Goel A. Characteristic patterns of altered DNA methylation predict emergence of human
hepatocellular carcinoma. Hepatology 2012;56:994-1003.
45. Makarova-Rusher OV, Altekruse SF, McNeel TS, et al. Population attributable fractions of risk factors for hepatocellular carcinoma in the
United States. Cancer 2016;122:1757-65.
46. Rubin JB, Lagas JS, Broestl L, et al. Sex differences in cancer mechanisms. Biol Sex Differ 2020;11:17.
47. Lemieux S, Prud’homme D, Bouchard C, Tremblay A, Després JP. Sex differences in the relation of visceral adipose tissue accumulation
to total body fatness. Am J Clin Nutr 1993;58:463-7.
48. Laughlin GA, Barrett-Connor E, May S. Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older
adults: the Rancho Bernardo Study. Clin Endocrinol (Oxf) 2006;65:506-13.
49. Manieri E, Herrera-Melle L, Mora A, et al. Adiponectin accounts for gender differences in hepatocellular carcinoma incidence. J Exp Med
2019;216:1108-19.
50. Lönnqvist F, Nordfors L, Jansson M, Thörne A, Schalling M, Arner P. Leptin secretion from adipose tissue in women. Relationship to
plasma levels and gene expression. J Clin Invest 1997;99:2398-404.
51. Augustine LM, Fisher CD, Lickteig AJ, et al. Gender divergent expression of Nqo1 in Sprague Dawley and August Copenhagen x Irish
rats. J Biochem Mol Toxicol 2008;22:93-100.
52. Kratschmar DV, Calabrese D, Walsh J, et al. Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11beta-
HSD1-mediated glucocorticoid activation in hepatic cells. PLoS One 2012;7:e36774.
53. Hofer T, Karlsson HL, Möller L. DNA oxidative damage and strand breaks in young healthy individuals: a gender difference and the role
of life style factors. Free Radic Res 2006;40:707-14.
54. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.
Science 2007;317:121-4.
55. Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats.
Hepatology 1999;29:719-27.
56. Xie G, Wang X, Zhao A, et al. Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. Sci Rep 2017;7:45232.
57. Tenkorang MA, Snyder B, Cunningham RL. Sex-related differences in oxidative stress and neurodegeneration. Steroids 2018;133:21-27.
58. Liu P, Xie SH, Hu S, et al. Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States. Oncotarget
2017;8:68131-7.
59. Santos-Marcos JA, Rangel-Zuniga OA, Jimenez-Lucena R, et al. Influence of gender and menopausal status on gut microbiota. Maturitas
2018;116:43-53.
60. Santos-Marcos JA, Haro C, Vega-Rojas A, et al. Sex differences in the gut microbiota as potential determinants of gender predisposition
to disease. Mol Nutr Food Res 2019;63:e1800870.
61. Kim YS, Unno T, Kim BY, et al. Sex differences in gut microbiota. World J Mens Health 2020;38:48-60.
62. Hassan MM, Botrus G, Abdel-Wahab R, et al. Estrogen replacement reduces risk and increases survival times of women with
hepatocellular carcinoma. Clin Gastroenterol Hepatol 2017;15:1791-9.
63. Sukocheva OA. Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet? World J Gastroenterol 2018;24:1-4.
64. Kalra M, Mayes J, Assefa S, et al. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J Gastroenterol
2008;14:5945-61.